Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Interventional × eflapegrastim × Clear all

Phase

Status

Sponsor Class

INDUSTRY 6 OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 1

Interventions

Cyclophosphamide 1774 Radiotherapy 1638 Cisplatin 1563 Carboplatin 1330 Gemcitabine 1238 Paclitaxel 1129 Bevacizumab 1092 Docetaxel 1061 pembrolizumab 1044 Capecitabine 1010 Oxaliplatin 1006 Fluorouracil 947 Dexamethasone 852 Rituximab 801 Nivolumab 793 Magnetic Resonance Spectroscopy 747 Etoposide 725 Doxorubicin 716 Irinotecan 678 Drug Therapy 673 Radiosurgery 671 Cytarabine 645 fludarabine 629 Leucovorin 601 Lenalidomide 539 fludarabine phosphate 494 Temozolomide 482 Radiation 477 Filgrastim 473 Cetuximab 465

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05949333 2024-02-23

NEUTHREE

Eunseong Medical Foundation Good GANG-AN HOSPITAL

Phase 4 Unknown

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡